<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36533348</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1671-167X</ISSN><JournalIssue CitedMedium="Print"><Volume>54</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>18</Day></PubDate></JournalIssue><Title>Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences</Title><ISOAbbreviation>Beijing Da Xue Xue Bao Yi Xue Ban</ISOAbbreviation></Journal><ArticleTitle>[Cortical thickness and cognitive impairment in patients with amyotrophic lateral sclerosis].</ArticleTitle><Pagination><StartPage>1158</StartPage><EndPage>1162</EndPage><MedlinePgn>1158-1162</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with high morbidity and mortality. There are about 5%-15% of ALS patients combining with frontotemporal lobe degeneration (FTLD) at the same time and 50% of patients combing with cognitive function changes. The analysis of cortical thickness based on MRI is an important imaging method to evaluate brain structure. The aim of the study was to explore the changes of brain structure in ALS patients by cortical thickness analysis, and to explore the correlation between the brain structure and cognitive function.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In the study, 18 ALS patients treated in Department of Neurology, Peking University Third Hospital and 18 normal controls (age, gender and education level matched) were included. 3D magnetization prepared rapid gradient echo imaging (MPRAGE) sequence MRI was performed and the cortical thickness was analyzed. At the same time, all the ALS patients took neuropsychology assessments, including: mini-mental state examination (MMSE), verbal fluency test (VFT), Stroop color word test (SCWT), prospective memory (PM), emotional picture perception and recognition, and faux pas story test.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">After cognitive assessment, two ALS patients had cognitive impairment. One was in accordance with ALS-frontotemporal dementia (FTD) diagnosis and the other one was in accordance with ALS cognitive impairment (ALSci) diagnosis. In all the 18 ALS patients and 18 normal controls, the cortical thickness of the left medial orbitofrontal lobe and the medial temporal lobe were significantly reduced (<i>P</i> &lt; 0.05) in ALS group by the vertex-wise comparison. Cortical thickness of the left entorhinal cortex, the left inferior temporal gyrus, the left medial orbitofrontal lobe and the left insular lobe was significantly reduced (<i>P</i> &lt; 0.05) by the region-wise comparison. However, when only concluded the 16 ALS non-cognitive impairment patients, there was no significant difference between the two groups (<i>P</i>&gt;0.05). There were correlations between the scores of prospective memory, emotional picture perception and recognition, faux pas story test and the cortical thickness of their corresponding regions (<i>P</i> &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The cortical thickness of ALS patients are correlated with neuropsychological scores which may reflect the changes of cortical structure corresponding to the cognitive assessment, and may provide help for the early diagnosis of cognitive changes in ALS patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>P P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>H B</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Department of Radiology, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Special Administrative Region 000852, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BrainNow Research Institute, Shenzhen 518000, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Q</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Radiology, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Radiology, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>H S</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Radiology, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>D S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing 100191, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Beijing Da Xue Xue Bao Yi Xue Ban</MedlineTA><NlmUniqueID>101125284</NlmUniqueID><ISSNLinking>1671-167X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText Label="&#x76ee;&#x7684;">&#x901a;&#x8fc7;MRI&#x76ae;&#x5c42;&#x539a;&#x5ea6;&#x5206;&#x6790;&#x6cd5;&#xff0c;&#x63a2;&#x8ba8;&#x808c;&#x840e;&#x7f29;&#x4fa7;&#x7d22;&#x786c;&#x5316;(amyotrophic lateral sclerosis, ALS)&#x60a3;&#x8005;&#x8111;&#x7ed3;&#x6784;&#x53d8;&#x5316;&#xff0c;&#x5e76;&#x5206;&#x6790;&#x5176;&#x4e0e;&#x8ba4;&#x77e5;&#x529f;&#x80fd;&#x6539;&#x53d8;&#x7684;&#x76f8;&#x5173;&#x6027;&#x3002;</AbstractText><AbstractText Label="&#x65b9;&#x6cd5;">&#x7eb3;&#x5165;ALS&#x60a3;&#x8005;18&#x4f8b;&#xff0c;&#x4ee5;&#x53ca;&#x6027;&#x522b;&#x3001;&#x5e74;&#x9f84;&#x3001;&#x6559;&#x80b2;&#x7a0b;&#x5ea6;&#x5339;&#x914d;&#x7684;&#x6b63;&#x5e38;&#x5bf9;&#x7167;&#x8005;18&#x4f8b;&#xff0c;&#x5bf9;&#x6240;&#x6709;&#x7814;&#x7a76;&#x5bf9;&#x8c61;&#x8fdb;&#x884c;3D&#x78c1;&#x5316;&#x51c6;&#x5907;&#x5feb;&#x901f;&#x9012;&#x5ea6;&#x56de;&#x6ce2;(magnetization prepared rapid gradient echo imaging, MPRAGE)&#x5e8f;&#x5217;MRI&#x626b;&#x63cf;&#xff0c;&#x8fdb;&#x884c;&#x76ae;&#x5c42;&#x539a;&#x5ea6;&#x5206;&#x6790;&#xff0c;&#x540c;&#x65f6;&#x5bf9;&#x6240;&#x6709;ALS&#x60a3;&#x8005;&#x8fdb;&#x884c;&#x795e;&#x7ecf;&#x5fc3;&#x7406;&#x5b66;&#x6d4b;&#x8bc4;&#xff0c;&#x5305;&#x62ec;&#x7b80;&#x6613;&#x7cbe;&#x795e;&#x72b6;&#x6001;&#x68c0;&#x67e5;(mini-mental state examination&#xff0c;MMSE)&#x3001;&#x8a00;&#x8bed;&#x6d41;&#x7545;&#x6027;&#x8bd5;&#x9a8c;&#x3001;Stroop&#x8272;&#x8bcd;&#x8bd5;&#x9a8c;&#x3001;&#x524d;&#x77bb;&#x6027;&#x8bb0;&#x5fc6;&#x3001;&#x60c5;&#x7eea;&#x56fe;&#x7247;&#x611f;&#x77e5;&#x53ca;&#x518d;&#x8ba4;&#x3001;&#x5931;&#x8a00;&#x8bc6;&#x522b;&#x6d4b;&#x9a8c;&#x3002;</AbstractText><AbstractText Label="&#x7ed3;&#x679c;">&#x7ecf;&#x8fc7;&#x8ba4;&#x77e5;&#x8bc4;&#x4f30;&#xff0c;2&#x4f8b;ALS&#x60a3;&#x8005;&#x5b58;&#x5728;&#x8ba4;&#x77e5;&#x529f;&#x80fd;&#x969c;&#x788d;&#x3002;&#x6bd4;&#x8f83;18&#x4f8b;ALS&#x60a3;&#x8005;&#x548c;18&#x4f8b;&#x6b63;&#x5e38;&#x5bf9;&#x7167;&#x7684;&#x9876;&#x70b9;&#x6c34;&#x5e73;&#x5168;&#x8111;&#x76ae;&#x5c42;&#x539a;&#x5ea6;&#xff0c;ALS&#x7ec4;&#x5de6;&#x4fa7;&#x5927;&#x8111;&#x534a;&#x7403;&#x5185;&#x4fa7;&#x7736;&#x989d;&#x53f6;&#x540e;&#x90e8;&#x3001;&#x989e;&#x53f6;&#x5185;&#x4fa7;&#x76ae;&#x5c42;&#x539a;&#x5ea6;&#x660e;&#x663e;&#x51cf;&#x4f4e;(<i>P</i> &lt; 0.05)&#xff1b;&#x533a;&#x57df;&#x6c34;&#x5e73;&#x6bd4;&#x8f83;&#xff0c;ALS&#x7ec4;&#x5de6;&#x5185;&#x55c5;&#x533a;&#x3001;&#x5de6;&#x989e;&#x4e0b;&#x56de;&#x3001;&#x5de6;&#x5185;&#x4fa7;&#x7736;&#x989d;&#x53f6;&#x3001;&#x5de6;&#x5c9b;&#x53f6;&#x76ae;&#x5c42;&#x539a;&#x5ea6;&#x660e;&#x663e;&#x51cf;&#x4f4e;(<i>P</i> &lt; 0.05)&#x3002;&#x8ba4;&#x77e5;&#x529f;&#x80fd;&#x6b63;&#x5e38;&#x7684;16&#x4f8b;ALS&#x60a3;&#x8005;&#x4e0e;&#x6b63;&#x5e38;&#x5bf9;&#x7167;&#x76f8;&#x6bd4;&#x8f83;&#xff0c;&#x4e24;&#x7ec4;&#x95f4;&#x9876;&#x70b9;&#x6c34;&#x5e73;&#x548c;&#x533a;&#x57df;&#x6c34;&#x5e73;&#x7684;&#x76ae;&#x5c42;&#x539a;&#x5ea6;&#x5dee;&#x5f02;&#x5747;&#x65e0;&#x7edf;&#x8ba1;&#x5b66;&#x610f;&#x4e49;(<i>P</i>&gt;0.05)&#x3002;&#x524d;&#x77bb;&#x6027;&#x8bb0;&#x5fc6;&#x3001;&#x60c5;&#x7eea;&#x56fe;&#x7247;&#x611f;&#x77e5;&#x53ca;&#x518d;&#x8ba4;&#x3001;&#x5931;&#x8a00;&#x8bc6;&#x522b;&#x6d4b;&#x9a8c;&#x8bc4;&#x5206;&#x4e0e;&#x5bf9;&#x5e94;&#x8111;&#x533a;&#x76ae;&#x5c42;&#x539a;&#x5ea6;&#x503c;&#x5b58;&#x5728;&#x76f8;&#x5173;&#x6027;(<i>P</i> &lt; 0.05)&#x3002;</AbstractText><AbstractText Label="&#x7ed3;&#x8bba;">ALS&#x60a3;&#x8005;&#x76ae;&#x5c42;&#x539a;&#x5ea6;&#x4e0e;&#x795e;&#x7ecf;&#x5fc3;&#x7406;&#x5b66;&#x68c0;&#x67e5;&#x5177;&#x6709;&#x76f8;&#x5173;&#x6027;&#xff0c;&#x53ef;&#x80fd;&#x53cd;&#x6620;&#x8ba4;&#x77e5;&#x6d4b;&#x8bc4;&#x6240;&#x5bf9;&#x5e94;&#x7684;&#x8111;&#x533a;&#x76ae;&#x5c42;&#x7ed3;&#x6784;&#x6539;&#x53d8;&#xff0c;&#x53ef;&#x80fd;&#x4e3a;ALS&#x60a3;&#x8005;&#x8ba4;&#x77e5;&#x6539;&#x53d8;&#x7684;&#x65e9;&#x671f;&#x8bca;&#x65ad;&#x63d0;&#x4f9b;&#x5e2e;&#x52a9;&#x3002;</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Cerebral cortex</Keyword><Keyword MajorTopicYN="N">Cognition</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>19</Day><Hour>4</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36533348</ArticleId><ArticleId IdType="pmc">PMC9761824</ArticleId><ArticleId IdType="doi">10.19723/j.issn.1671-167X.2022.06.016</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Strong M, Abrahams S, Goldstein L, et al. Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(3/4):153&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanstock C, Sun K, Choi C, et al. Spectroscopic markers of neurodegeneration in the mesial prefrontal cortex predict survival in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(3/4):246&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pubmed">32067510</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F, Nardo F, Siciliano M, et al. Frontotemporal degeneration in amyotrophic lateral sclerosis (ALS): A longitudinal MRI one-year study. CNS Spectr. 2021;26(3):258&#x2013;267. doi: 10.1017/S109285292000005X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S109285292000005X</ArticleId><ArticleId IdType="pubmed">32089134</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu T, Hou Y, Wei Q, et al. Patterns of brain regional functional coherence in cognitive impaired ALS. Int J Neurosci. 2020;130(8):751&#x2013;758. doi: 10.1080/00207454.2019.1705806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00207454.2019.1705806</ArticleId><ArticleId IdType="pubmed">31906800</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Desikan RS, Segonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31(3):968&#x2013;980. doi: 10.1016/j.neuroimage.2006.01.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2006.01.021</ArticleId><ArticleId IdType="pubmed">16530430</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiara C, Alessandra D, Stefano FC, et al. Multimodal MRI quantification of the common neurostructural bases within the FTD-ALS continuum. Neurobiol Aging. 2018;62:95&#x2013;104. doi: 10.1016/j.neurobiolaging.2017.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.09.019</ArticleId><ArticleId IdType="pubmed">29131982</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraete E, Veldink JH, Hendrikse J, et al. Structural MRI reveals cortical thinning in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;83(4):383&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">21965521</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmann M. Motor neuron disease/amyotrophic lateral sclerosis: Lessons from ubiquitin. Pathol Res Pract. 1993;189(8):902&#x2013;912. doi: 10.1016/S0344-0338(11)81102-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0344-0338(11)81102-7</ArticleId><ArticleId IdType="pubmed">8302713</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen D, Hou B, Cui B, et al. Comparing brain structural and perfusion MRI changes across ALS-FTD continuum. Clin Neurophysiol. 2018;129:e162.</Citation></Reference><Reference><Citation>Labar KS, Cabeza R. Cognitive neuroscience of emotional memory. Nat Rev Neurosci. 2006;7(1):54&#x2013;64. doi: 10.1038/nrn1825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1825</ArticleId><ArticleId IdType="pubmed">16371950</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolcos F, Labar KS, Cabeza R. Dissociable effects of arousal and valence on prefrontal activity indexing emotional evaluation and subsequent memory: An event-related fMRI study. Neuro-image. 2004;23(1):64&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">15325353</ArticleId></ArticleIdList></Reference><Reference><Citation>Lule D, Diekmann V, Anders S, et al. Brain responses to emotional stimuli in patients with amyotrophic lateral sclerosis (ALS) J Neurol. 2007;254(4):519&#x2013;527. doi: 10.1007/s00415-006-0409-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-006-0409-3</ArticleId><ArticleId IdType="pubmed">17401515</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>